A Study to Evaluate the Botulinum Toxin Type A for Injection(HengLi®) in Subjects With Post-stroke Upper Limb Spasticity
Clinical trial NCT02280083 · COMPLETED
Trial details
- NCT number
- NCT02280083
- Sponsor
- Lanzhou Institute of Biological Products Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2016-02-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.